101 related articles for article (PubMed ID: 31140285)
1. Prognostic influence of CDX2 expression in gastric carcinoma after surgery with a curative intent.
Estrada Muñoz L; García Gómez de Las Heras S; Díaz Del Arco C; Cerón Nieto MA; Chicharro Uriguen J; Fernández Aceñero MJ
Rev Esp Enferm Dig; 2019 Jul; 111(7):514-518. PubMed ID: 31140285
[TBL] [Abstract][Full Text] [Related]
2. CDX2 as a prognostic marker in gastric cancer.
Masood MA; Loya A; Yusuf MA
Acta Gastroenterol Belg; 2016; 79(2):197-200. PubMed ID: 27382937
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
[TBL] [Abstract][Full Text] [Related]
4. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.
Ge J; Chen Z; Wu S; Yuan W; Hu B; Chen Z
Clin Oncol (R Coll Radiol); 2008 May; 20(4):275-83. PubMed ID: 18353622
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.
Camilo V; Barros R; Celestino R; Castro P; Vieira J; Teixeira MR; Carneiro F; Pinto-de-Sousa J; David L; Almeida R
BMC Cancer; 2014 Oct; 14():753. PubMed ID: 25300947
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
7. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
Fan Z; Li J; Dong B; Huang X
Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
[TBL] [Abstract][Full Text] [Related]
8. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
9. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures.
Wang XT; Wei WY; Kong FB; Lian C; Luo W; Xiao Q; Xie YB
J Exp Clin Cancer Res; 2012 Nov; 31(1):98. PubMed ID: 23181722
[TBL] [Abstract][Full Text] [Related]
11. CDX2 expression can predict response to neoadjuvant therapy in gastric carcinoma.
Fernández Aceñero MJ; Sánchez de Molina ML; Caso A; Vorwald P; Olmo DG; Palomar J; Estrada L; Díaz Del Arco C
Rom J Morphol Embryol; 2017; 58(4):1275-1278. PubMed ID: 29556617
[TBL] [Abstract][Full Text] [Related]
12. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis.
Bai Z; Ye Y; Chen D; Shen D; Xu F; Cui Z; Wang S
APMIS; 2007 Dec; 115(12):1383-90. PubMed ID: 18184409
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
Xiong ZF; Xiao H; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
[TBL] [Abstract][Full Text] [Related]
14. CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications.
Seno H; Oshima M; Taniguchi MA; Usami K; Ishikawa TO; Chiba T; Taketo MM
Int J Oncol; 2002 Oct; 21(4):769-74. PubMed ID: 12239615
[TBL] [Abstract][Full Text] [Related]
15. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M
J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
[TBL] [Abstract][Full Text] [Related]
17. Association of CDX2 Expression With Survival in Early Colorectal Cancer: A Systematic Review and Meta-analysis.
Tomasello G; Barni S; Turati L; Ghidini M; Pezzica E; Passalacqua R; Petrelli F
Clin Colorectal Cancer; 2018 Jun; 17(2):97-103. PubMed ID: 29519711
[TBL] [Abstract][Full Text] [Related]
18. [Expression of intestine-specific transcription factor CDX2 in different subtypes of intestinal metaplasia and gastric carcinoma].
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
Ai Zheng; 2006 Feb; 25(2):185-9. PubMed ID: 16480583
[TBL] [Abstract][Full Text] [Related]
19. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations.
Schildberg CW; Abba M; Merkel S; Agaimy A; Dimmler A; Schlabrakowski A; Croner R; Leupold JH; Hohenberger W; Allgayer H
Adv Med Sci; 2014 Mar; 59(1):142-6. PubMed ID: 24797991
[TBL] [Abstract][Full Text] [Related]
20. Further prognostic stratification of intestinal type of gastric adenocarcinoma by CDX2 expression pattern.
Hao Y; Liu BL; Liang Y; Xiong Y; Polydorides AD; Ward S
Hum Pathol; 2023 Jan; 131():61-67. PubMed ID: 36403867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
